Xconomy National

Archives

by in

Entry	Author	Date	Location
Caxton Advantage to Raise $150 Million	Arlene Weintraub	03/25/11	New York
Who Should You Start a Company With? As Seattle Evolves, FounderDating Has an Answer	Gregory T. Huang	01/29/10	Seattle
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic	Luke Timmerman	08/26/09	Boston
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines	Luke Timmerman	08/25/09	San Diego
VC Rick Klausner on the Future of Vaccines, and Why Dendreon is Only Scratching the Surface	Luke Timmerman	08/19/09	Seattle
Spark-funded Clear Shuts Down	Wade Roush	06/23/09	Boston
What’s a Biotech Banker To Do in a Downturn? How About M&A	Luke Timmerman	03/16/09	Seattle
BIO Boss Plays Defense as Member Companies Struggle to Survive, Political Heat Cranks Up	Luke Timmerman	02/26/09	National
Ironwood, Flush With Cash, Anticipates Big Year with Constipation Drug	Luke Timmerman	11/21/08	Boston
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies	Luke Timmerman	11/18/08	San Diego
Boston Scientific Co-Founders Sell Stock; Didn’t Mean It, Company Says	Luke Timmerman	10/09/08	Boston
The Camera is Watching You: VideoIQ Puts Smarts into Surveillance	Wade Roush	07/09/08	Boston
A Mighty Wind: Noble Environmental Power Files for $375M IPO	Gregory T. Huang	05/09/08	Boston
Polaris Senior Associate and GreenFuel VP Nick Sinai Joining Lehman Brothers Venture Arm in Boston	Robert Buderi	12/07/07	Boston
ExaGrid Pulls in $20 Million Series C Round in Bid to Replace Tape-Based Backup	Wade Roush	11/08/07	Boston
Page 1 of 1